SHARx VP of Sourcing & Pharmacy Relations Otto Graham shares his perspective on prescription affordability and examines growing concerns among patients…
As employers face rising healthcare costs and difficult decisions surrounding GLP-1 medications heading into 2027, businesses must look beyond traditional…
SHARx CGO and co-founder Paul Pruitt shares his perspective on prescription affordability and healthcare access to a public-affairs audience interested…
SHARx CGO and co-founder Paul Pruitt highlights the continued importance of international pharmaceutical markets in helping Americans access affordable prescription…
Prescription drug utilization continues to reshape employer healthcare costs, particularly with the growing use of GLP-1s, specialty medications and other…